Comparing two pill combinations for new diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes within the last 5 years.
- You are 18 to 75 years old.
- You are not currently on any diabetes medication, or you are taking only metformin.
- You are willing to take one of the study combination pills and follow the study rules.
- You do not have serious health issues like heart failure, kidney disease, active cancer, or a history of pancreatitis.
- You are not pregnant, planning to become pregnant, or have a condition that might affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This trial compares two different combinations of diabetes pills (metformin plus empagliflozin with either sitagliptin or linagliptin) in people with type 2 diabetes who have not been treated before. It aims to see which combination works better and is safer for controlling blood sugar.
This study tests a new medication called TriGlytza-01 against the standard diabetes drug metformin. It is for adults with type 2 diabetes who are overweight or obese and whose blood sugar is not well controlled with metformin alone.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
Hear when a new Type 2 Diabetes (Adult Onset) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.